Global Benign Prostatic Hyperplasia Market Research Report 2023

Report ID: 1975111 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Benign Prostatic Hyperplasia Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Drug Therapy
        1.2.3 Dialysis
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Benign Prostatic Hyperplasia Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Benign Prostatic Hyperplasia Market Perspective (2017-2028)
    2.2 Benign Prostatic Hyperplasia Growth Trends by Region
        2.2.1 Benign Prostatic Hyperplasia Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Benign Prostatic Hyperplasia Historic Market Size by Region (2017-2022)
        2.2.3 Benign Prostatic Hyperplasia Forecasted Market Size by Region (2023-2028)
    2.3 Benign Prostatic Hyperplasia Market Dynamics
        2.3.1 Benign Prostatic Hyperplasia Industry Trends
        2.3.2 Benign Prostatic Hyperplasia Market Drivers
        2.3.3 Benign Prostatic Hyperplasia Market Challenges
        2.3.4 Benign Prostatic Hyperplasia Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Benign Prostatic Hyperplasia Players by Revenue
        3.1.1 Global Top Benign Prostatic Hyperplasia Players by Revenue (2017-2022)
        3.1.2 Global Benign Prostatic Hyperplasia Revenue Market Share by Players (2017-2022)
    3.2 Global Benign Prostatic Hyperplasia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Benign Prostatic Hyperplasia Revenue
    3.4 Global Benign Prostatic Hyperplasia Market Concentration Ratio
        3.4.1 Global Benign Prostatic Hyperplasia Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia Revenue in 2021
    3.5 Benign Prostatic Hyperplasia Key Players Head office and Area Served
    3.6 Key Players Benign Prostatic Hyperplasia Product Solution and Service
    3.7 Date of Enter into Benign Prostatic Hyperplasia Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Benign Prostatic Hyperplasia Breakdown Data by Type
    4.1 Global Benign Prostatic Hyperplasia Historic Market Size by Type (2017-2022)
    4.2 Global Benign Prostatic Hyperplasia Forecasted Market Size by Type (2023-2028)
5 Benign Prostatic Hyperplasia Breakdown Data by Application
    5.1 Global Benign Prostatic Hyperplasia Historic Market Size by Application (2017-2022)
    5.2 Global Benign Prostatic Hyperplasia Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Benign Prostatic Hyperplasia Market Size (2017-2028)
    6.2 North America Benign Prostatic Hyperplasia Market Size by Country (2017-2022)
    6.3 North America Benign Prostatic Hyperplasia Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Benign Prostatic Hyperplasia Market Size (2017-2028)
    7.2 Europe Benign Prostatic Hyperplasia Market Size by Country (2017-2022)
    7.3 Europe Benign Prostatic Hyperplasia Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Benign Prostatic Hyperplasia Market Size (2017-2028)
    8.2 Asia-Pacific Benign Prostatic Hyperplasia Market Size by Country (2017-2022)
    8.3 Asia-Pacific Benign Prostatic Hyperplasia Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Benign Prostatic Hyperplasia Market Size (2017-2028)
    9.2 Latin America Benign Prostatic Hyperplasia Market Size by Country (2017-2022)
    9.3 Latin America Benign Prostatic Hyperplasia Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Benign Prostatic Hyperplasia Market Size (2017-2028)
    10.2 Middle East & Africa Benign Prostatic Hyperplasia Market Size by Country (2017-2022)
    10.3 Middle East & Africa Benign Prostatic Hyperplasia Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Benign Prostatic Hyperplasia Introduction
        11.1.4 Abbott Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Detail
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Benign Prostatic Hyperplasia Introduction
        11.2.4 Allergan Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.2.5 Allergan Recent Development
    11.3 Astellas Pharma
        11.3.1 Astellas Pharma Company Detail
        11.3.2 Astellas Pharma Business Overview
        11.3.3 Astellas Pharma Benign Prostatic Hyperplasia Introduction
        11.3.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.3.5 Astellas Pharma Recent Development
    11.4 Boehringer Ingelheim Pharma
        11.4.1 Boehringer Ingelheim Pharma Company Detail
        11.4.2 Boehringer Ingelheim Pharma Business Overview
        11.4.3 Boehringer Ingelheim Pharma Benign Prostatic Hyperplasia Introduction
        11.4.4 Boehringer Ingelheim Pharma Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.4.5 Boehringer Ingelheim Pharma Recent Development
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Company Detail
        11.5.2 Eli Lilly and Company Business Overview
        11.5.3 Eli Lilly and Company Benign Prostatic Hyperplasia Introduction
        11.5.4 Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.5.5 Eli Lilly and Company Recent Development
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Detail
        11.6.2 GlaxoSmithKline Business Overview
        11.6.3 GlaxoSmithKline Benign Prostatic Hyperplasia Introduction
        11.6.4 GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.6.5 GlaxoSmithKline Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Benign Prostatic Hyperplasia Introduction
        11.7.4 Merck Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.7.5 Merck Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Detail
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Benign Prostatic Hyperplasia Introduction
        11.8.4 Pfizer Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.8.5 Pfizer Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Detail
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Benign Prostatic Hyperplasia Introduction
        11.9.4 Sanofi Revenue in Benign Prostatic Hyperplasia Business (2017-2022)
        11.9.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Benign Prostatic Hyperplasia Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Drug Therapy
    Table 3. Key Players of Dialysis
    Table 4. Key Players of Others
    Table 5. Global Benign Prostatic Hyperplasia Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Benign Prostatic Hyperplasia Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Benign Prostatic Hyperplasia Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Benign Prostatic Hyperplasia Market Share by Region (2017-2022)
    Table 9. Global Benign Prostatic Hyperplasia Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Benign Prostatic Hyperplasia Market Share by Region (2023-2028)
    Table 11. Benign Prostatic Hyperplasia Market Trends
    Table 12. Benign Prostatic Hyperplasia Market Drivers
    Table 13. Benign Prostatic Hyperplasia Market Challenges
    Table 14. Benign Prostatic Hyperplasia Market Restraints
    Table 15. Global Benign Prostatic Hyperplasia Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Benign Prostatic Hyperplasia Market Share by Players (2017-2022)
    Table 17. Global Top Benign Prostatic Hyperplasia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia as of 2021)
    Table 18. Ranking of Global Top Benign Prostatic Hyperplasia Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Benign Prostatic Hyperplasia Product Solution and Service
    Table 22. Date of Enter into Benign Prostatic Hyperplasia Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Benign Prostatic Hyperplasia Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Benign Prostatic Hyperplasia Revenue Market Share by Type (2017-2022)
    Table 26. Global Benign Prostatic Hyperplasia Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Benign Prostatic Hyperplasia Revenue Market Share by Type (2023-2028)
    Table 28. Global Benign Prostatic Hyperplasia Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Benign Prostatic Hyperplasia Revenue Market Share by Application (2017-2022)
    Table 30. Global Benign Prostatic Hyperplasia Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Benign Prostatic Hyperplasia Revenue Market Share by Application (2023-2028)
    Table 32. North America Benign Prostatic Hyperplasia Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Benign Prostatic Hyperplasia Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Benign Prostatic Hyperplasia Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Benign Prostatic Hyperplasia Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Benign Prostatic Hyperplasia Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Benign Prostatic Hyperplasia Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Benign Prostatic Hyperplasia Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Benign Prostatic Hyperplasia Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Benign Prostatic Hyperplasia Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Benign Prostatic Hyperplasia Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Abbott Company Detail
    Table 43. Abbott Business Overview
    Table 44. Abbott Benign Prostatic Hyperplasia Product
    Table 45. Abbott Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 46. Abbott Recent Development
    Table 47. Allergan Company Detail
    Table 48. Allergan Business Overview
    Table 49. Allergan Benign Prostatic Hyperplasia Product
    Table 50. Allergan Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 51. Allergan Recent Development
    Table 52. Astellas Pharma Company Detail
    Table 53. Astellas Pharma Business Overview
    Table 54. Astellas Pharma Benign Prostatic Hyperplasia Product
    Table 55. Astellas Pharma Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 56. Astellas Pharma Recent Development
    Table 57. Boehringer Ingelheim Pharma Company Detail
    Table 58. Boehringer Ingelheim Pharma Business Overview
    Table 59. Boehringer Ingelheim Pharma Benign Prostatic Hyperplasia Product
    Table 60. Boehringer Ingelheim Pharma Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 61. Boehringer Ingelheim Pharma Recent Development
    Table 62. Eli Lilly and Company Company Detail
    Table 63. Eli Lilly and Company Business Overview
    Table 64. Eli Lilly and Company Benign Prostatic Hyperplasia Product
    Table 65. Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 66. Eli Lilly and Company Recent Development
    Table 67. GlaxoSmithKline Company Detail
    Table 68. GlaxoSmithKline Business Overview
    Table 69. GlaxoSmithKline Benign Prostatic Hyperplasia Product
    Table 70. GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 71. GlaxoSmithKline Recent Development
    Table 72. Merck Company Detail
    Table 73. Merck Business Overview
    Table 74. Merck Benign Prostatic Hyperplasia Product
    Table 75. Merck Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 76. Merck Recent Development
    Table 77. Pfizer Company Detail
    Table 78. Pfizer Business Overview
    Table 79. Pfizer Benign Prostatic Hyperplasia Product
    Table 80. Pfizer Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 81. Pfizer Recent Development
    Table 82. Sanofi Company Detail
    Table 83. Sanofi Business Overview
    Table 84. Sanofi Benign Prostatic Hyperplasia Product
    Table 85. Sanofi Revenue in Benign Prostatic Hyperplasia Business (2017-2022) & (US$ Million)
    Table 86. Sanofi Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Benign Prostatic Hyperplasia Market Share by Type: 2021 VS 2028
    Figure 2. Drug Therapy Features
    Figure 3. Dialysis Features
    Figure 4. Others Features
    Figure 5. Global Benign Prostatic Hyperplasia Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Benign Prostatic Hyperplasia Report Years Considered
    Figure 9. Global Benign Prostatic Hyperplasia Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Benign Prostatic Hyperplasia Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Benign Prostatic Hyperplasia Market Share by Region: 2021 VS 2028
    Figure 12. Global Benign Prostatic Hyperplasia Market Share by Players in 2021
    Figure 13. Global Top Benign Prostatic Hyperplasia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Revenue in 2021
    Figure 15. North America Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Benign Prostatic Hyperplasia Market Share by Country (2017-2028)
    Figure 17. United States Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Benign Prostatic Hyperplasia Market Share by Country (2017-2028)
    Figure 21. Germany Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Benign Prostatic Hyperplasia Market Share by Region (2017-2028)
    Figure 29. China Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Benign Prostatic Hyperplasia Market Share by Country (2017-2028)
    Figure 37. Mexico Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Benign Prostatic Hyperplasia Market Share by Country (2017-2028)
    Figure 41. Turkey Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Benign Prostatic Hyperplasia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbott Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 44. Allergan Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 45. Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 46. Boehringer Ingelheim Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 47. Eli Lilly and Company Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 50. Pfizer Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 51. Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Allergan
Astellas Pharma
Boehringer Ingelheim Pharma
Eli Lilly and Company
GlaxoSmithKline
Merck
Pfizer
Sanofi
Frequently Asked Questions
Benign Prostatic Hyperplasia report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Benign Prostatic Hyperplasia report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Benign Prostatic Hyperplasia report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Laser Photomask

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More